Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Neurobiol Aging. 2019 Mar 15;84:242.e1–242.e6. doi: 10.1016/j.neurobiolaging.2019.03.004

Figure 1.

Figure 1.

Survival curves measuring effect of HMGCR rs3846662 intron 13 on Alzheimer’s Disease (AD) free survival. (a) Male age of onset of AD in rs3846662 G non-carriers vs. G carriers (p-value = 0.161). (b) Female age of onset of AD in rs3846662 G non-carriers vs. G carriers (p-value = 0.327). (c) Age of onset of AD in males vs females (p-value = 0.059). (d) Age of onset of AD in rs3846662 G non-carriers vs. G carriers (p-value = 0.102). (e) Age of onset of AD in rs3846662 G carrier males vs. females (p-value =0.209). (f) Age of onset of AD in rs3846662 G non-carrier males vs. females (p-value = 0.134)